Here are the 10-Q quarterly reports from First Choice Hlthcre Inc (FCHS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow FCHS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FCHS filings page.
First Choice Healthcare Solutions, Inc. reported a very small operating platform and a heavily leveraged capital structure for the six months ended June 30, 2026. Total assets were $576,493 against total liabilities of $10,084,581, leaving a stockholders’ deficit of $9,508,087, improved from a $39,528,075 deficit at December 31, 2025, mainly due to large debt-for-equity conversions and lease/AP settlements.
Operations remain minimal: revenue for the first half of 2026 was $3,406, while operating expenses were about $1.27 million, producing an operating loss of $1,267,310. Net loss attributable to common shareholders expanded to $8,447,243 (loss per share $0.26) from $2,037,329 (loss per share $0.06) in the prior-year period, driven largely by $7,385,781 of interest expense tied to convertible and other debt and their conversion to preferred equity.
Liquidity is strained: cash was only $6,842 and the company had a working capital deficit, while all non-convertible and convertible notes are classified as current. Management discloses substantial doubt about the ability to continue as a going concern without additional capital or successful execution of its growth and acquisition strategy. After quarter-end, the company signed a Business Combination Agreement with Westin Acquisition Corp. and binding agreements to acquire several Pointe Med entities, aiming to build a broader healthcare platform.
First Choice Healthcare Solutions filed its Q3 10‑Q, reporting a net loss of $1,462,888 on revenue of $230 for the quarter ended September 30, 2025. For the nine months, net loss was $3,500,214 on revenue of $5,686.
Cash was $2,430 as of September 30, 2025, against current liabilities of $37,160,986 and total liabilities of $40,155,246. The company reported a stockholders’ deficit of $(36,042,136). Convertible notes payable totaled $13,749,153, all classified as current. Operating cash outflow was $552,485 year‑to‑date, while financing inflow was $525,000 from new convertible notes.
The notes disclose SBA confirmation of $471,300 PPP loan forgiveness on April 24, 2025. Management states substantial doubt about the company’s ability to continue as a going concern absent additional capital or cost reductions. Common shares outstanding were 32,958,288 as of November 11, 2025.